The invention relates to sample analysis, and, more particularly, a sample acquisition device.
A biological specimen from a living (e.g., a human patient) or nonliving source (e.g., a food preparation surface) may be obtained via a sample acquisition device for bioburden testing. Bioburden testing may include, for example, the determination of the number of organisms with which the specimen is contaminated. For example, a sample from a patient's open wound may be acquired in order to determine whether the wound is contaminated with potentially hazardous microorganisms.
One type of conventional sample acquisition device is a medical swab with a fibrous nonwoven tip at one end of a stem. A user may manually handle the swab by grasping the stem and placing the swab tip in contact with selected tissue cells or other biological specimens, e.g., from within the ear, nose, throat or open wound of a patient. Some of the targeted tissue cells or biological specimen adheres to the swab tip, thereby defining a biological sample for analysis. Tests that may be performed with the acquired sample include, for example, fluorescent tests, enzymatic tests, monoclonal based tests, agglutination tests, and the like.
In general, the invention is directed to a sample acquisition device including a body defining a plurality of sample acquisition regions between at least a first wall and a second wall oriented generally nonparallel to the first wall. In one embodiment, the second wall defines a sloped surface into the sample acquisition region when the body is rotated in a first direction. The sample acquisition regions may be defined by, for example, a plurality of apertures defined by the body, a plurality of projections extending from the body or any combination of apertures or projections. In some embodiments, the apertures comprise a plurality of elongated grooves that extend in a direction substantially along a length of an elongated body of the sample acquisition device. In other embodiments, the apertures comprise truncated openings that may be arranged in rows or in an irregular pattern. In other embodiments, the sample acquisition regions are defined between a plurality of projections extending from the body, where the projections may extend in one or more directions.
In one embodiment of a technique for acquiring a sample with a sample acquisition device described herein, a user may place the body of the sample acquisition device in contact with a sample source and rotate the body in a first direction. The user may apply pressure to further engage the body with a sample surface of the source. As the body is rotated in the first direction, sample particles are captured in at least some of the sample acquisition regions. The sample may be any suitable state, and is not limited to a liquid or solid state. In embodiments in which at least one of the sample acquisition regions comprises a wall that provides an inclined surface into the sample acquisition region when the body is rotated in the first direction, the sloped wall encourages sample particles to move into the sample acquisition region.
In some embodiments, the first and second walls of the sample acquisition region may remove sample particles from the sample source by an abrasive action. In other embodiments, the sample acquisition regions receive sample particles by capillary force in addition to or instead of abrasive action.
In some techniques for removing the sample from the sample acquisition device, the user may introduce the body into a buffer solution and rotate the body in a second direction that is substantially opposite to the first direction. Some bodies described herein include sample acquisition regions that are configured to release the sample with less energy when rotated in the second direction compared to rotating in the first direction.
In one embodiment, the invention is directed to a sample acquisition device comprising a stem and a body coupled to the stem and defining a plurality of sample acquisition regions. At least one of the sample acquisition regions is defined between at least a first wall and a second wall oriented generally nonparallel to the first wall.
In one embodiment, the invention is directed to a sample acquisition device comprising a stem defining a longitudinal axis and a body coupled to the stem and defining a plurality of apertures disposed at various lateral positions around the body. At least one of the apertures comprises at least a first wall and a second wall, where the second wall defines a surface that is inclined into the respective aperture when the body is rotated in a first direction about the longitudinal axis of the stem.
In another embodiment, the invention is directed to a method comprising placing a body of a sample acquisition device in contact with a sample source to acquire a sample, the body defining a plurality of sample acquisition regions, where at least one of the sample acquisition regions comprises a first wall and a second wall oriented nonparallel to the first wall, and rotating the body relative to the sample source in a first direction to acquire the sample in at least one of the sample acquisition regions.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
In some embodiments, apertures 16 are configured to remove sample particles from a sample source by abrasive action, which results when body 14 is engaged with the sample source and rotated in the first direction 17A. In other embodiments, apertures 16 are configured to receive sample particles by capillary force in addition to or instead of the abrasive action. The sample source may be from a living or nonliving patient. Examples of living sources include, but are not limited to, a human patient's wound, ear, nose, throat, and the like. Examples of nonliving sources include, but are not limited to, a food preparation surface or utensil.
The sample acquired via sample acquisition device 10 may be utilized for any suitable purpose. For example, in one embodiment, the sample may be tested for bioburden, e.g., the number of microorganisms present in the sample, or for the presence of target microorganisms (e.g., staphylococcus aureus). Other example procedures that may be conducted with the sample acquired via sample acquisition device 10 includes preparation of a biological sample for, for example, DNA sequencing, and/or detection, diagnostic or analytical procedures, chemical, biological or biochemical reactions, and the like. Examples of such reactions include detection via thermal processing techniques, such as, but not limited to, enzyme kinetic studies, homogeneous ligand binding assays, and more complex biochemical or other processes that require precise thermal control and/or rapid thermal variations. Other examples of tests performed with an acquired sample include fluorescent tests, enzymatic tests, monoclonal based tests, agglutination tests, and the like.
Stem 12 may be any suitable elongated member that defines a structure that a user may manually grasp in order to place body 14 in contact with a sample source. Stem 12 may be formed of any suitable material that exhibits sufficient rigidity to enable the user to control the position of body 14 and rotate body 14 relative to a sample source. For example, stem 12 may be formed of paper (e.g., cardboard), a polymer, steel (e.g., stainless steel), a metal alloy, and the like. In some embodiments, sample acquisition device 10 is disposable after minimal use, e.g., one use. Accordingly, in some cases, the material for stem 12 and body 14 may be selected to minimize the cost of the device 10.
Body 14 may be any suitable structure that defines a plurality of apertures 16. In some embodiments, body 14 is essentially non-absorbent or non-absorbent with respect to the sample with which body 14 is used to acquire. In addition, in some embodiments, body 14 is made at least in part of a material that exhibits some compliancy (v. rigidity) relative to the sample source. The compliancy of body 14 relative to the sample source may help minimize damage to the sample source, while enabling body 14 to remove sample particles from the sample source by abrasive action. For example, body 14 may be formed at least in part of nylon, metal or a polymer, such as polysulfone, polypropylene, polytetrafluoroethylene (PTFE), polyacrylates, polyethylene, polyvinylidene difluoride (PVDF) or polycarbonate. In some embodiments in which body 14 acquires a sample by abrasive action, it may be desirable for body 14 to exhibit a sufficient level of hardness to enable a user to press body 14 toward the sample source and generate friction between body 14 and the sample source, e.g., to abrade sample particles from the source by a scraping action.
In some embodiments, body 14 may be formed from a thermoplastic materials suitable for casting, profile extrusion, molding, solid freeform fabrication or embossing including, such as, but not limited to, polyolefins, polyesters, polyamides, poly(vinyl chloride), polymethyl methacrylate, polycarbonate, nylon, and the like. Other sample acquisition characteristics of the material forming body 14 may include substantial inertness relative to the sample or a relatively low rate of elution of chemicals or other contaminants that may affect a sample analysis process, e.g., when the sample is released from body 14.
As previously described, in some embodiments, body 14 acquires a sample by capillary force in addition to abrasive action. For example, apertures 16 may each define a capillary structure that obtains and retains a sample from a sample source by capillary pressure. Alternatively, two or more of apertures 16 may be in fluid communication to define a common capillary structure. Accordingly, in some cases, a material for body 14 may be selected to have a particular surface energy to achieve capillary action to draw the sample into apertures 16. The surface energy may be selected based upon the surface energy of the sample that is acquired by device 10.
In some embodiments, body 14 is formed of a material having a surface energy in a range of about 40 dynes/centimeter squared (dyn/cm2) to about 82 dyn/cm2, such as about 50 dyn/cm2 to about 72 dyn/cm2. In some embodiments, the material for body 14 is selected to have a surface energy close to that of water, or about 72 dyn/cm2. In some embodiments, body 14 may include a base material that does not necessarily include the desired sample acquisition characteristics, and an external layer (e.g., a coating) comprising a material that affords hydrophilic, hydrophobic, positively-charged or negatively-charged surfaces to achieve the desired sample acquisition characteristics. For example, an inorganic coating (e.g., a silica coating) or an organic coating (e.g., polymeric coatings, such as polyacrylate) may afford hydrophilic characteristics to apertures 16. Surface energy (or surface tension) characteristics of a material forming body 16 may also be achieved with the aid of physical treatments, such as, but not limited to, corona treating in which the material being treated is exposed to an electrical discharge, or corona, electron beam treatments.
A sample that is retained within apertures 16 by capillary force may be easier to remove from body 14 compared to a conventional medical swab that includes a fibrous tip because the sample is held within apertures 16 by adsorption, rather than absorption, as is the case with some conventional medical swabs. For example, less energy may be required to release the sample particles from apertures 16 compared to sample particles that are bound to fibers of a conventional medical swab.
In the embodiment shown in
Apertures 16 define a plurality of sample acquisition regions that capture and contain the sample. The shape of each of apertures 16 may be circular, oval, rectangular, square, or irregular. In the embodiment shown in
Apertures 16 may be sized to retain a maximum sample volume in order to meter the quantity of sample a user may obtain with sample acquisition device 10. Controlling the maximum volume of sample acquired with sample acquisition device 10 may help minimize variability in sample size attributable to different users or user techniques for handling device 10. The maximum sample volume may be selected, for example, based on the sample analysis tests performed with the sample. Some sample analysis processes are sensitive to sample quantities, and, accordingly, a device 10 that helps a user meter the quantity of sample obtained may be useful. In the embodiment shown in
Sample acquisition device 10 provides advantages over conventional medical swabs that are often used to acquire a sample from a source for further analysis. Conventional medical swabs typically include a fibrous non-woven tip in a teardrop or ellipsoidal shape at one end of a stem. Typically, a user manually grasps the stem of the medical swab and places the fibrous tip in contact with the select tissue cells or other specimen to be obtained, e.g., from within a wound, ear, nose or throat of a human patient. Some of the targeted specimen adheres to the fibrous swab tip.
The conventional tip of the swab typically has a relatively large sample acquisition surface area to volume held by the swab, thereby increasing the possibility of the specimen binding to the fibers of the swab tip and being unavailable for sample analysis. Variability in the composition of the nonwoven material (e.g., rayon) of the fibrous swab tip, which may result from the type of nonwoven material and the construction of the swab, as well as variability in the user technique employed to acquire the sample may affect the quantity of sample that adheres to the swab tip. For example, depending on the user or the particular batch of swabs used to acquire a sample, the quantity of sample acquired by two different swabs may differ. As one example, the fibers forming the tip of a conventional swab may differ in absorption characteristics or in an ability to bind to sample particles from batch to batch. The variance in sample size may affect the quality of sample analysis. Some sample analysis techniques may provide substantially inaccurate or varying if a sample size is not within a particular range. Thus, sample acquisition by conventional swabs may adversely affect some sample analysis techniques.
In contrast to a conventional sample acquisition device, sample acquisition device 10 is designed to minimize variability in acquired sample volume that may be attributable to different acquisition techniques (e.g., based on different users) or different batches of devices. As previously described, apertures 16 of sample acquisition device 10 are designed to acquire a substantially fixed quantity of a sample from a sample source. Apertures 16 are designed to hold a maximum volume of a sample, which may meter the volume of sample a user acquires. Some detection techniques that provide different results based on the quantity of sample analyzed, thus, it may be desirable to acquire a particular sample volume.
In some embodiments, such as embodiments in which body 14 is manufactured by an injection molding process, variance in the size of apertures 16 may be minimized, thereby minimizing variance in sample volume that may be attributable to the batch of sample acquisition devices 10. In addition, the quantity of chemicals that may contaminate or interfere with the analysis of the acquired sample may be minimized embodiments in which body 14 is comprised of a polymer or steel. On the other hand, the fibrous tip of medical swabs may include chemicals transfer to the sample when the sample is eluted from the swab. These chemicals may contaminate or interfere with the analysis of the sample. For example, some fibrous swab tips may include various adhesives (e.g., to adhere the fibrous material to a stem), binders, surfactants, processing aids, and soluble oligomers that interfere with a detection technique.
Depending upon the construction of the medical swab, fibers from the fibrous tip may transfer to the sample source, which may be undesirable. For example, in the case of an open wound in a human patient, transfer of fibers from the medical swab to the open wound may agitate the wound, and in some cases, encourage infection of the wound. As another example, contaminating a food preparation surface with fibers may increase the risk of transferring fibers to food placed on the surface. Body 14 is formed of a material that exhibits fewer transferable chemicals compared to a fibrous tip of a conventional swab, and, accordingly, the possibility of the material of body 14 contaminating a sample or interfering with analysis of a sample is decreased when a sample is acquired via sample acquisition device compared to a convention swab including a fibrous tip.
Aperture 16A includes first wall 18 and second wall 20, which are defined by body 14. As shown in the top view of aperture 16A, shown in
As shown in
At the widest point WA of aperture 16A measured along top surface 15 of body 15, (shown in
In the embodiment shown in
Bacteria present in a human patient's nasal cavity may be embedded within a nasal biofilm, which may have the consistency of a gel or another nonliquid state. It may be difficult to capture the biofilm with conventional swabs (or “swab applicators”) that include a fibrous bud composed of cotton, rayon or other fibers. While these swabs may be useful for retaining liquid samples, in the case of the nonliquid biofilm, the conventional swab tip may merely spread the biofilm around while capturing a minimal amount, if any, of the biofilm. In contrast, sample acquisition device 10 includes a body 14 defining a plurality of sample acquisition regions 16 that may capture and retain the biofilm or another nonliquid sample.
In cases in which sample surface 26 is not compliant (e.g., a stainless steel food preparation counter), a portion of sample surface 26 may not be drawn into aperture 16A. Nevertheless, the inclined surface defined by wall 20 opens aperture 16A towards the sample surface and encourages the entry of sample particles into aperture 16A as the particles are scraped or otherwise removed from the sample surface by body 14.
Returning now to
In the embodiment shown in
While a generally ovoid body 14 is shown in
As previously described, a sample retained by body 14 may be subsequently analyzed for detection of a particular microorganism or another sample analysis process. In some cases, the sample is combined with a reagent for a subsequent sample preparation or analysis process. In some embodiments, body 14 may include one or more reagents or other chemicals that are used in a subsequent sample preparation or analysis process. For example, the reagent may be coated or otherwise applied within apertures 16. Thus, when the sample is drawn into apertures 16, the sample may begin reacting with the reagent.
In some embodiments, body 14 may include a reagent such as, but are not limited to, a lysis reagent (e.g., lysostaphin, lysozyme, mutanolysin or other enzymes), a protein-digesting reagent, a nucleic acid amplifying enzyme, an oligonucleotide, a probe, nucleotide triphosphates, a buffer, a salt, a surfactant, a dye, a nucleic acid control, a nucleic acid amplifying enzyme, a reducing agent, dimethyl sulfoxide (DMSO), glycerol, ethylenediaminetetraacetic acid (EDTA), ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), microspheres capable of binding a nucleic acid, and a combination thereof. In addition, in some embodiments, the reagent is selected from a group including RNase, DNase, an RNase inhibitor, a DNase inhibitor, Bovine Serum Albumin, spermidine, and a preservative. Other reagents may include salts, buffers that regulate the pH of reaction media involved in the sample analysis or preparation, dyes, detergents or surfactants that lyse or de-clump cells, improve mixing or enhance fluid flow.
As described above, when body 14 is rotated in a first direction, sample particles, regardless of the state (e.g., liquid or solid) of the sample, are received in at least some of apertures 16 by abrasive action (e.g., mechanical scraping of the particles into the apertures 16), by capillary force or combinations thereof. The user may rotate body 14 any suitable number of times. In some embodiments, body 14 may be rotated one or less than one full rotation while engaged with the sample source in order to acquire the sample. In other embodiments, body 14 may be rotated multiple times.
The user may also place different portions of outer surface 15 of body 14 in contact with the sample surface. Because outer surface 15 of body 14 has a proximal portion and distal portion with varying radii (in the cross-section taken substantially perpendicular to center axis 24 of body 14), the entire outer surface 15 may not simultaneously contact the sample source if the sample source defines, e.g., a generally planar surface. Accordingly, in some cases, the user may reorient center axis 24 of body 14 relative to the sample source in order to reposition outer surface 15 relative to a surface of the sample source.
After acquiring the sample, the user may withdraw body 14 from the sample surface (34). In some cases, the user may protect body 14 from contaminants, e.g., with a cap for storage or transportation to a sample analysis site. Alternatively, the user may release the sample from body 14. In the technique shown in
While the user may also rotate body 14 in the first direction 17A or agitate body 14 within the buffer solution in a nonspecific pattern, it is believed that in some embodiments, the configuration of apertures 16 are conducive to releasing a sample when body 14 is rotated in the second direction 17B, i.e., in a direction substantially opposite to the direction in which the respective wall 20 of each aperture 16 is angled. That is, in some embodiments, less energy is required to release the sample from apertures 16 when body 14 is rotated in the second direction 17B. This may be partially attributable to the inclined surface defined by wall 18. Just as wall 20 defines a surface that is inclined into aperture 16 when body 14 is rotated in the first direction 17A, the surface defined by wall 20 may also help guide sample particles out of apertures 16 when body 14 is rotated in the second direction 17B.
As previously described, in some embodiments, body 14 may be formed form a material, such as a polymer, that minimizes or eliminates the amount of a liquid buffer solution that body 14 retains when at least partially submerged in the buffer solution. This may help maximize the amount of sample that is released into buffer solution from apertures 16 and increase the efficiency with which the sample is released from apertures 16. In addition, the material for body 14 may be selected to minimize the amount of additives or other materials released into the buffer solution during the sample release step. In the case of many conventional swabs, the fibers of the conventional swab bud may be coated with carboxy methyl cellulose (CMC) in order to help the fibers hold their bud-like structure. When the conventional swab bud is exposed to a wash solution, the CMC and other additives in the swab bud may be leached out into the wash solution. The CMC and other additives may impact a subsequent sample analysis technique. Body 14 described herein helps minimize or even eliminate the exudates that are released from the sample acquisition device compared to a conventional swab bud.
In some embodiments of sample acquisition device 10, stem 12 may define an inner lumen that is in fluid communication with apertures 16. In order to elute an acquired sample from apertures 16, a user may introduce rinse fluid into the inner lumen defined by stem 12 and into body 14, such that the fluid flows through apertures 16. A flow member, such as a nylon, polycarbonate, PTFE or PVDF membrane, may be disposed between the lumen of stem 12 and body 14 in order to help distribute the fluid across a majority or all of apertures 16.
In some embodiments, a compartment, such as a deformable bulb or syringe, including the rinse fluid (or buffer solution) may be mechanically and fluidically coupled to an opposite end of stem 12 from body 14. In some embodiments, the rinse fluid may include a reagent that is useful for sample preparation or analysis. The fluid compartment may store a volume of rinse fluid that is sufficient to elute substantially all of the sample from apertures 16 as the rinse fluid flows through stem 12 and through apertures 16. For example, the fluid compartment may store a volume of rinse fluid that is about five times to about twenty times the total maximum sample volume apertures 16 are designed to retain. The fluid compartment may include a mechanism to retain the rinse fluid in the compartment until release is desired. For example, a mechanical valve (e.g., a snap valve), laser valve or a membrane that may be ruptured by applying pressure to the membrane may be disposed between the inner lumen of stem 12 and the fluid compartment.
The embodiment of body 14 shown in
In each of the embodiments of sample acquisition devices shown in
Walls 58, 60 are oriented at an angle AG relative to each other. Angle AG may be selected such that when body 50 is rotated in a first direction, as indicated by arrow 64 (
As shown in
Walls 78A-78D are generally aligned with dividing members 74A-74D, respectively, such that dividing members 74A-74D are extensions of walls 78A-78D that extend from body 70. Accordingly, dividing members 74A-74D are generally orthogonal to adjacent dividing members. Dividing members 74A-74D extend from outer surface 72 of body 70 and help scrape or otherwise abrade sample particles from a surface of a sample source, which may help increase the quantity of sample obtained via one rotation of body 70 or the sample acquisition area of the sample source. In addition, dividing members 74A-74D may define additional sample acquisition regions for additional sample retention capacity. Because dividing members 74A-74D protrude from a side of body 70 other than the side in which grooves 76A-76D are positioned, dividing members 74A-74D also help device 70 acquire a sample from an irregularly shaped sample source, e.g., a sample source including one or more surfaces extending in more than one dimension. In one embodiments, dividing members 74A-74D protrude from outer surface 72 of body 70 a distance P of about 1 mm to about 2 mm, such as about 1.5 mm.
In some embodiments, dividing members 74A-D and grooves 76A-76D are shaped (e.g., via an extrusion manufacturing technique) to have a variable cross-section along its width WDM. For example, dividing members 74A-D may have a cross-sectional size along its width WDM that decreases away from outer surface 72, similar to a converging blade of a knife. Dividing members 74A-74D may also be flexible in some embodiments, which may allow dividing members 74A-74D to deform and conform to different sample surfaces when body 70 is rotated in one or both directions about center axis 71. Flexible dividing members 74A-74D may help remove particles of a solid sample, as well as a fluid or semi-fluid (e.g., a consistency of a gel) from a sample source, similar to a squeegee blade.
In order to acquire a sample from a source, such as sample surface 26 (
Although a body 70 including four dividing members 74A-74D and four grooves 76A-76D is shown in
Some sample acquisition regions 98 are defined by a projection 94, which may define a first wall, and an adjacent projection 96, which may define an opposing, second wall that is generally nonparallel to the first wall. In addition, some sample acquisition regions 98 are defined by the space between adjacent projections 94, as well as between adjacent projections 96.
Projections 96 are oriented at various angles relative to longitudinal axis 100 of body 90. Projection 96A, which is representative of the other projections 96, is curvilinear. First end 102A of projection 96A has a first circumferential position on outer surface 92 of body 90 and second end 102B has a second circumferential position that is different than the first circumferential position. Thus, the first and second ends 102A, 102B of projection 96A are laterally displaced from each other. Due to the curvilinear shape of projection 96A, projection 96A defines a surface 104 that is sloped toward sample acquisition region 98A to help draw a sample into region 98A when body 90 is rotated in a direction indicated by arrow 105 (
As shown in
First end 102A of projection 96A and second end 106B of projection 94A overlap in a longitudinal direction such that a sample acquisition surface 98A is defined between surfaces 104 and 108 of projections 96A and 94A, respectively. In addition, a sample acquisition region 98B is defined between surface 104 of projection 96A and an opposing surface 110 of projection 96B. Surfaces 104 and 110 may be oriented at substantially similar angles relative to longitudinal axis 100 of body 90, and, in some cases, surfaces 104 and 110 may be generally parallel to each other. Regardless of whether surfaces 104 and 110 are generally parallel or nonparallel, surface 104 of projection 96A defines a wall that provides a sloped surface into sample acquisition region 98B when sample is rotated in direction 105 about axis 100.
Projection 94B is adjacent to projection 94A and defines a surface 112 that is substantially orthogonal to surface 108 of projection 94A. A space between surfaces 108 and 112 defines a sample acquisition region 98C. In embodiments in which projections 94 define angled surfaces, rather than surfaces that are substantially parallel to a plane in which longitudinal axis 100 of body 94 lays.
While outer surface 92 and projections 94, 96 may be designed such that they exhibit a surface energy that supports capillary action, body 90 acquires a sample primarily by abrasive action that results when projections 94 and 96 engage with the sample surface. Capillary force exhibited by sample acquisition regions 98 of body 90 may be minimal when compared to the capillary force exhibited by apertures 16 of body 14 (
Just as with dividing members 74A-74D of
Each projection 124 is generally nonparallel to an adjacent projection 124. Accordingly, sample acquisition regions 128 defined between projections 124 include generally nonparallel walls that are defined by adjacent projections 124. In the embodiment shown in
Each projection 126 is generally nonparallel to an adjacent projection 126. Accordingly, sample acquisition regions 130 defined between projections 126 include generally nonparallel walls that are defined by adjacent projections 126. Just as with projections 124, projections 126 define surfaces that define an inclined surface into the respective sample acquisition region 130.
Just as with dividing members 74A-74D of
In contrast to grooves 54 of body 50 (
As previously described, in order to acquire a sample with a sample acquisition device including a body defining one or more sample acquisition regions with at least a first wall and a second wall that is nonparallel to the first wall, a user may rotate the body in a particular direction. The user may manually rotate the body or rotate the body with the aid of a device.
While sample acquisition device 10 and body 14 (
In the embodiment shown in
Once secured in opening 164, stem 12 is coupled to a motor of device 160. The motor may be, for example, an electric motor that is controlled by a processor. A user may depress button 166 in order to activate the motor and rotate stem 12 in the first direction 17A (shown in
If rotation of body 14 in the second direction 17B (
In other embodiments, device 160 may include other mechanisms for activating the motor and selecting a direction of rotation. For example, device 160 may include a switch that is movable, where different positions of the switch are associated with different directions of rotations and, in some cases, speeds of rotation. As another example, device 160 may include a touch screen display that defines selectable regions associated with different directions of rotation and, in some cases, speeds of rotation.
For the right nare of each subject, a rayon swab was introduced into the right nostril a sufficient amount to introduce the rayon tip into the nostril, approximately 1 cm. The rayon swab was rotated approximately three complete rotations relative to the mucosal surface and then withdrawn from the nostril. After introducing the rayon swab into the nostril, body 150 was introduced into the right nostril a sufficient amount to introduce body 150 into the nostril, approximately 1 cm, and rotated approximately three complete rotations relative to the mucosal surface. Similar techniques were used to acquire samples in the left nostril of the subject with a different rayon swab and different device including body 150.
After sample collection, the conventional rayon swabs and bodies 140 were placed into separate sterile 15 milliliter (mL) polypropylene centrifuge tubes. In order to extract the sample from the devices, 1000 microliters (μL) of a phosphate buffer saline (PBS), 10 mM sodium phosphate, 150 millimol (mM) sodium chloride, pH 7.5 (PBS) solution including 0.05% by volume of Tween 20 (PBS-Tween 20) was introduced into each polypropylene centrifuge tube containing either a rayon swab or a body 150.
Each polypropylene centrifuge tube containing a sample acquisition device was vortexed using a high setting of the VWR Vortex Mixer (120 Volts, 50/60 Hertz, 75 Watt) (VWR International, Batavia, Ill.). The devices were then removed from the respective centrifuge tubes and 1:10 serial dilutions in a PBS-Tween 20 buffer solution were performed. The swab extract solutions and its dilutions were plated in duplicate onto separate sheep blood agar (SBA) plates (Hardy Diagnostics, Santa Maria, Calif.). The plated samples were incubated at approximately 37 degrees Celsius (plus or minus one degree Celsius) for approximately 48 hours. After incubation, the plates were examined for growth. Plates in the dilution series having a range of about 25 CFU to about 250 CFU were counted. A total plate count for all colony types along with the dilution are shown in
The results shown in
Various embodiments of the invention have been described. These and other embodiments are within the scope of the following claims. Reference to the orthogonal x-y-z axes throughout the present disclosure is used to aid the description of sample acquisition devices and is not intended to limit the scope of the present invention. In addition, in each the embodiments described herein, stem 12 may define an inner lumen that is in fluid communication with the sample acquisition regions, regardless of whether the sample acquisition regions are defined by apertures or by projections.
While reference is made to first and second directions of rotation of each of the sample acquisition devices described above, the invention is not so limiting. A user may acquire a sample with the sample acquisition device, release a sample from the sample acquisition device, or may otherwise handle the sample acquisition devices using any suitable technique. For example, the user may rotate the bodies of the devices in the opposite directions described above in order to acquire a sample. As another example, the user may move the sample acquisition device relative to the sample site in a non-rotational pattern or another irregular pattern.
This application claims the benefit of U.S. Provisional Application Ser. No. 61/029,087, filed Feb. 15, 2008, which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US09/33869 | 2/12/2009 | WO | 00 | 3/28/2011 |
Number | Date | Country | |
---|---|---|---|
61029087 | Feb 2008 | US |